chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Injection site induration, Lipase normal, Lumbar puncture, Lymphadenopathy, Lymphocyte count decreased
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Mean cell haemoglobin, Mean cell haemoglobin increased, Metabolic function test, Metabolic function test normal, Monocyte count increased
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Neutrophil count increased, Nuclear magnetic resonance imaging abnormal, Nuclear magnetic resonance imaging thoracic abnormal, Painful respiration, Prothrombin time normal
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Pyrexia, Red blood cell count decreased, Red blood cell sedimentation rate increased, Red blood cells CSF positive, Sinus rhythm
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Troponin I increased, Urine analysis normal, Ventricular hypokinesia
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Pericarditis
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, FLU3, SMALL, FLUX, SMALL, FLUX, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Pericarditis, Troponin I increased
Clinical narrative: This study case was received from the investigator on 10 March 2011. A 26 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis 12 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 28 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 02.05, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 May 2011 via a third party query tool search on the VAERS database, and provided VAERS reference number 418965. Documents held by sender: none.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Headache, Lymphadenopathy, Malaise, Pruritus generalised, Vaccination complication
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 398658. A 19-year-old male patient received the following vaccinations on 31 August 2010: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number B10262), BIOTHRAX (lot number FAV248). The patient had no medical history, and was not ill at the time of vaccination. On an unreported date, he experienced multiple satellite lesions over his entire body, including his face, mouth, torso, legs, groin, and arms. He complained of general pruritis, headache, swollen lymph nodes, and generally "feeling lousy". He was afebrile. The patient required an emergency visit; outcome was not reported. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Secondary transmission, Sunburn
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 398930.  A 24 year-old male patient with a history of alopecia and fatigue, had received the following vaccinations on 01 September 2010: an intradermal injection of ACAM2000 (lot number VV04003A) and an intramuscular injection of BIOTHRAX (lot number FAV242) and seven days later, experienced multiple secondary transmissions inferior to primary site and sunburn. The patient had no systemic symptoms. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Acne, Alanine aminotransferase increased, Application site odour, Arthralgia, Aspartate aminotransferase increased
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Axillary pain, Bacterial test negative, Blood calcium decreased, Blood cholesterol increased, Blood culture negative
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Blood immunoglobulin A normal, Blood immunoglobulin E increased, Blood immunoglobulin G normal, Blood immunoglobulin M decreased, Blood phosphorus decreased
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: C-reactive protein normal, CD4 lymphocytes decreased, Culture stool negative, Culture wound positive, Cytomegalovirus test negative
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Enterovirus test negative, Eosinophil percentage increased, Epstein-Barr virus antibody positive, Folliculitis, Gram stain negative
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: HIV antibody negative, Helicobacter test negative, Hepatitis B surface antibody positive, Herpes simplex serology negative, Injection site discolouration
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Injection site erythema, International normalised ratio normal, Lymphadenectomy, Lymphadenopathy, Monocyte count increased
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Mononucleosis heterophile test negative, Mycoplasma test positive, Oral disorder, Pain, Pain in extremity
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Parvovirus B19 test positive, Protein total normal, Prothrombin time normal, Rash, Rash erythematous
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Rash pruritic, Red blood cell sedimentation rate normal, Staphylococcus test positive, T-lymphocyte count decreased, Treponema test negative
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Treponema test positive, Urine analysis normal, Varicella virus test positive, Viral test positive, White blood cell count normal
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 399524. A 20-year-old male patient received ACAM2000 (lot not reported) and a second dose of anthrax vaccine (manufacturer and lot not reported) on 11 August 2010. No medical history or concurrent illness was reported. On Day 7, the patient complained that the injection site "smelled bad"; the site was described as white with a red circle. He also complained of axillary pain, lymphadenopathy, and body aches in the hips and legs which resolved after 3 days. Approximately 26 August 2010, he developed several small pruritic red bumps to bilateral forearms, legs, and calves. The bumps later progressed to small pimples with white heads; it was noted that the patient shaved his arms, and thought the rash was folliculitis. He subsequently developed lesions on the lips and mouth, with red dots on the palms of hands and soles of feet. He presented to the medical clinic, where he was transferred to a hospital and admitted. Laboratory testing indicated a high IgE and low normal CD3 count; IgA and IgG were normal. Additionally, alanine aminotransferase was increased, anti-HBS antibody was positive, aspartate aminotransferase was increased, bacterial test was negative, blood calcium was decreased, blood cholesterol was increased, blood cultures were negative, IgM was decreased, blood phosphorus was decreased, C-reactive protein was normal, CD4 lymphocytes were decreased, stool culture was negative, wound culture was positive, cytomegalovirus antibody was negative, enterovirus test was negative, eosinophil percentage was increased, Epstein-Barr virus antibody was positive, gram stain was negative, Helicobacter pylori identification test was negative, monocyte count was increased, mononucleosis heterophile test was negative, mycoplasma serology was positive, parvovirus B19 test was positive, protein total was normal, prothrombin time was normal, red blood cell sedimentation rate was normal, staphylococcus test was positive, T-lymphocyte count was decreased, treponema test was negative, urine analysis was normal, varicella virus test was positive, viral test was positive, herpes simplex serology was negative, HIV antibody was negative, international normalized ratio was normal, and white blood cell count was normal. Due to a positive RPR, he was evaluated by an Infectious Disease specialist (results not reported). He also underwent a lymphadenectomy. The patient subsequently recovered on an unspecified date. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 37.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Injection site urticaria, Lymph node pain, Lymphadenopathy, Rash generalised
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 400402. A 37 year-old male patient (also reported as 38) had received the following vaccinations on 10 September 2010: an intradermal left arm injection of ACAM2000 (lot number VV04003A), an intramuscular right arm injection of TYPHIM VI (lot number D1087) and an intramuscular right arm injection of BIOTHRAX (lot number FAV242) and an unspecified amount of time later, experienced a "severe rash" over his entire body (from neck to toes) for ten days, left side of the body lymph node swelling and tenderness and hives reported on and around the injection site. He was evaluated in the emergency room. Treatments included BENADRYL and CLARITIN. No further information was available at the time of the report. The patient's outcome was not reported. A corrective version was created on 22 December 2010 to correct the route of administration from intradermal to percutaneous. Documents held by sender: none.
Age: 37.0
Sex: M
Vaccine: SMALL
Symptoms: Dyspnoea, Erythema, Lymphadenopathy, Night sweats, Tenderness
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 400476. A 37 year-old male patient had received on 10 September 2010 a percutaneous right arm injection of ACAM2000 (lot number W04003A) and 12 days later, experienced shortness of breath, kidney tenderness, cervical and axillary lymphadenopathy, night sweats and red streaks on right arm. He was evaluated in the emergency room and hospitalized (dates not provided). No further information was available at the time of the report. The patient's outcome was recovered (date not reported). Documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: FLU3, SMALL
Symptoms: Arthralgia, Mononucleosis heterophile test, Pain, Pyrexia, Rash
Clinical narrative: This case was received on 09 December 2010 via a QScan search on the VAERS database, under reference number 400550. A 26-year-old male patient received the following vaccinations on 16 September 2010: a percutaneous left arm ACAM2000 (lot number VV04003A, and right arm FLUZONE, lot number UH180AD. The patient's medical history included allergic rhinitis and myopia. The patient had no known drug allergies (NKDA) and his concomitant medications were not reported. On 25 September 2010, the patient developed a rash, fever, joint pain, and body aches. A mononucleosis heterophile test was performed and the result was pending. He was admitted to the hospital and was being transferred to a higher echelon of care. The outcome was reported as unknown. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: FLU3, SMALL
Symptoms: Erythema, Laboratory test normal, Mononucleosis heterophile test negative, Skin lesion, Streptococcus test
Clinical narrative: This case was received on 09 December 2010 via a third party query tool search on the VAERS database, under reference number 400740. A 26-year-old male patient, who had no concurrent illnesses, but did have medical history of allergy to IV dye and shellfish, had received the following vaccinations on 13 September 2010: ACAM2000 (lot number VV04-003-A), and FLUZONE (lot number UH180AD). Ten days post-vaccination on 23 September 2010 the patient developed scattered erythematous lesions on his face, scalp, neck and upper chest requiring emergency visit and hospitalization. Laboratory data revealed a negative Mono spot test and negative rapid streptococcus test. The patient's recovery status was reported as unknown. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: ANTH, FLUN3, SMALL
Symptoms: Culture throat, Oropharyngeal pain, Rash pustular, Skin lesion, Streptococcus test
Clinical narrative: This case was received on 09 December 2010 via a QScan search on the VAERS database, under reference number 401730. A 24-year-old male patient received the following vaccinations on 21 September 2010: a percutaneous left arm ACAM2000 (lot number VV04003A), intramuscular right arm BIOTHRAX (lot number FAV236) and intranasal FLUN (Medimmune, lot number 500431P). The patient had no medical history and no current illnesses. On 30 September 2010, the patient developed oropharyngeal pain, rash pustular and skin lesion. The patient stated he was eating on Saturday, 25 September 2010, when his smallpox bandage fell off his arm and landed in his food. The patient continued eating. Around 30 September 2010, the patient began experiencing a sore throat and noticed white pus pockets in the back of his throat. The patient was evaluated by a physician in the clinic. The patient had a throat culture performed (results not reported) to rule out streptococcus. The physician determined the pus pockets to be satellite lesions from the primary smallpox site. The outcome was reported as unknown. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: ANTH, FLUN3, SMALL
Symptoms: Throat lesion, Vaccination complication
Clinical narrative: This case was received on 09 December 2010 via a QScan search on the VAERS database, under reference number 401730. A 24-year-old male patient received the following vaccinations on 21 September 2010: a percutaneous left arm ACAM2000 (lot number VV04003A), intramuscular right arm BIOTHRAX (lot number FAV236) and intranasal FLUN (Medimmune, lot number 500431P). The patient had no medical history and no current illnesses. On 30 September 2010, the patient developed oropharyngeal pain, rash pustular and skin lesion. The patient stated he was eating on Saturday, 25 September 2010, when his smallpox bandage fell off his arm and landed in his food. The patient continued eating. Around 30 September 2010, the patient began experiencing a sore throat and noticed white pus pockets in the back of his throat. The patient was evaluated by a physician in the clinic. The patient had a throat culture performed (results not reported) to rule out streptococcus. The physician determined the pus pockets to be satellite lesions from the primary smallpox site. The outcome was reported as unknown. Documents held by sender: None.